Cardiotoxicity of doxorubicin: Effects of 21-aminosteroids

Life Sciences

Volumn 63, Issue 17, 1998, Pages 1525-1532

  Falcone, Giuseppe ^a   Filippelli, W ^a   Mazzarella, B ^c   Tufano, R ^c   Mastronardi, P ^c   Filippelli, A ^b   Berrino, L ^a   Rossi, F ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

21 aminosteroids; Cardiotoxicity; Doxorubicin

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 21 AMINOSTEROID; DOXORUBICIN; LAZAROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MORTALITY; NONHUMAN; RAT; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BODY WEIGHT; CHROMANS; DOXORUBICIN; ELECTROCARDIOGRAPHY; HEART; HEART DISEASES; MALE; PIPERAZINES; PREGNATRIENES; RATS; RATS, WISTAR; SURVIVAL RATE;

EID: 0032544547     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00419-6     Document Type: Article

References (37)

1. 1 P.D. THOMAS, G.D. MAO, A. RABINOVITCH and M.J. POZNANZKY, Biochem. Pharmacol. 45 241-250 (1993).
2. 2 W.M. CLARK, J.S. HAZEL and B.M. COULL, Drugs. 50 971-983 (1995).
3. 3. E.D. HALL, J.M. MCCALL and E.D. MEANS, Adv. Pharmacol. 28 221-265 (1994).
4. 4 R. PARONI, E. DE VECCHI, L. LUBATTI, E. CONTI, C. BERETTA, P. RINALDI, M. G. KIENLE and R. TRAZZI, Eur. J. Pharmacol. 294 737-742 (1995)
5. 5 N. AOKI and A.M. LEFER, J. Cardiovasc. Pharmacol. 15 205-210 (1990)
6. 6. F.P. CARREA, E.J. LESNEFSKY, D.G. KAISER and L.D. HORWITZ, J. Cardiovasc. Pharmacol. 20 230-235 (1992).
7. 7. K. SHAN, M. LINCOFF and J.B. YOUNG, Ann. Intern. Med. 125 47-58 (1996).
8. 8. H. AKIMOTO, N.A. BRUNO, D.L. SLATE, M.E. BILLINGHAM, S.V. TORTI and F.M. TORTI, Cancer Res. 53 4658-4664 (1993).
9. 9. C.F. SEIFERT, M. NESSER and F. THOMPSON, Ann. Pharmacother. 28 1063-1072 (1994).
10. 10 R.A. JENSEN, E.M. ACTON and J.H. PETERS, J. Cardiovasc. Pharmacol. 6 186-200 (1984)
11. 11. J.S. STEINBERG, A.J. COHEN, A.G. WASSERMAN, P. COHEN and A.M. ROSS, Cancer 60 1213-1218 (1987).
12. 12. L. LENAZ and J.A. PAGE, Cancer Treat Rev. 3 111-120 (1976).
13. 13. V.J. FERRANS, Cancer Treat. Rep. 62 955-961 (1978).
14. 14. M.R. BRISTOW, M.E. BILLINGHAM, J.W. MASON and J.R. DANIELS, Cancer Treat Rep. 62 873-879 (1978).
15. 15. M.A. FRIEDMAN, M.J BOZDECH, M.E. BILLINGHAM and A.K. RIDER, JAMA 240 1603-1606 (1978).
16. 16 M.M. HAQ, S. LEGHA, J CHOKSI, G.N. HORTOBAGYI, R.S. BENJAMIN and M. EWER, Cancer 56 1361-1365 (1985)
17. 17. L. STEINHERZ, P. STEINHERZ, C.T. TAN, G. HELLER and M.L. MURPHY, JAMA 266 1672-1677 (1991).
18. 18. S.E. LIPSHULTZ, S.D. COLAN, R.D. GELBER, A.R. PEREZ-ATAYDE, S.E. SALLAN and S.P. SANDERS, N. Engl. J. Med. 324 808-815 (1991)
19. 19. J.P. BUYNISKI ,and R.S. HIRTH, Anthracyclines - current status and new development, 157-170, Academic Press, New York. (1980).
20. 20. R.D. OLSON and P. S. MUSHLIN, FASEB J. 4 3076-3086 (1990)
21. 21 H. KUSUOKA, S. FUTAKI, Y. KORETSUNE, A KITABATAKE, H. SUGA and T. KAMADA, J Cardiovasc. Pharmacol. 18 437-444 (1991).
22. 22. P.K. SINGAL and G.N. PIERCE, Am J Physiol. 250 419-425 (1986).
23. 23. E. CHACON and D. ACOSTA, Toxicol. Appl. Pharmacol. 107 117-128 (1991).
24. 24. E. CHACON, R. ULRICH and D. ACOSTA, Biochem. J. 281 871-878 (1992)
25. 25 L.E. SOLEM, T.R. HENRY and K.B. WALLACE, Toxicol. Appl. Pharmacol. 129 214-222 (1994)
26. 26. J.L. SPEYER, M.D. GREEN and N. DUBIN, Am .J. Med. 78 555-563 (1985).
27. 27. J.L. SPEYER, M.D. GREEN and E, Kramer, N. Engl. J. Med. 319 745-752 (1988).
28. 28. E.H. HERMAN, V.J. FERRANS, C.E. MYERS and J.F. VLEET, Cancer. Res. 45 276-281 1985
29. 29. J.L. SPEYER, M.D. GREEN and A. ZELENIUCH-JAQUOTTE, J. Clin. Oncol. 10 117-127 (1992).
30. 30. B.B. HASINOFF, Agents Actions 29 374-381 (1990)
31. 31. S.R. HOLMBERG, D.V. CUMMING, Y. KUSAMA, D.J. HEARSE, P.A. POOLE-WILSON and M.J. SHATTOCK, Cardioscience 2 19-25 (1991)
32. 32. K.P. BURTON, A.C. MORRIS, K.D. MASSEY, L.M. BUJA and H.K. HAGLER, J. Mol Cell Cardiol. 22 1035-1047 (1990).
33. 33. S.R. HOLMBERG and A.J WILLIAMS., Circ. Res. 67 272-283 (1990)
34. 34. E. D. HALL, P.A. YONKERS and P.K. ANDRUS, J Neurotrauma 9 425-442 (1992).
35. 35. G. H. WOLFGANG, R. A. JOLLY, and T.W. PETRY, Free Rad. Biol. Med. 10 403-411 (1991)
36. 36. M.G. CAMPO, F. SQUADRITO, D. ALTAVILLA, G. SQUADRITO, A. AVENOSO P. CANALE, M. IOCULANO, A. SPERANDEO and A. P. CAPUTI, J. Pharm. Exp. Ther. 277 333-340 (1996).
37. 37. F. ROSSI, W. FILIPPELLI, S. RUSSO, A. FILIPPELLI and L. BERRINO, Pharmacol. Toxicol. 75 99-107 (1994).